Tumour-wide RNA splicing aberrations generate actionable public neoantigens.
Saved in:
| Title: | Tumour-wide RNA splicing aberrations generate actionable public neoantigens. |
|---|---|
| Authors: | Kwok DW; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Stevers NO; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Etxeberria I; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Parker Institute for Cancer Immunotherapy, New York, NY, USA., Nejo T; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Colton Cove M; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Chen LH; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Jung J; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Okada K; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Lakshmanachetty S; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Gallus M; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurosurgery, University Hospital Muenster, Muenster, Germany., Barpanda A; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA., Hong C; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Chan GKL; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Liu J; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Wu SH; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Ramos E; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA., Yamamichi A; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Watchmaker PB; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Ogino H; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Saijo A; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Du A; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Grishanina NR; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Woo J; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Diaz A; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Hervey-Jumper SL; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Chang SM; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Phillips JJ; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA.; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA., Wiita AP; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.; Chan Zuckerberg Biohub San Francisco, San Francisco, CA, USA., Klebanoff CA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. klebanoc@mskcc.org.; Parker Institute for Cancer Immunotherapy, New York, NY, USA. klebanoc@mskcc.org.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. klebanoc@mskcc.org., Costello JF; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA. joseph.costello@ucsf.edu., Okada H; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA. hideho.okada@ucsf.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. hideho.okada@ucsf.edu. |
| Source: | Nature [Nature] 2025 Mar; Vol. 639 (8054), pp. 463-473. Date of Electronic Publication: 2025 Feb 19. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
